Abbvie Inc. vs Axsome Therapeutics, Inc
ABBV vs AXSM — side-by-side comparison from reported financials. ABBV leads 5, AXSM leads 4 of 9 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Axsome Therapeutics, Inc
AXSM · Healthcare
$168.52-0.92%Solid
| Metric | ABBV | AXSM |
|---|---|---|
| Price | $276.43 | $168.52 |
| Market cap | $488B | $8.83B |
| Revenue (TTM) | $64.4B | $777M |
| Revenue growth | +1.8% | +133.7% |
| Net margin | 9.8% | -24.7% |
| Free cash flow | $18.2B | -$72.0M |
| Net cash (debt) | ($56.2B) | $205M |
| 1-year price return | +19.8% | +37.5% |
| P/E | 77.4 | — |
| P/E vs own history (cheap-side %) | 23% | — |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | -256% |
| Altman Z-score | 2.33 | 5.42 |
| CV checks passed | 9 of 11 | 5 of 11 |
| Employees | 57,000 | 925 |
Full résumé-style profiles: ABBV CV · AXSM CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.